2022 Capital Markets Day presentation

ROVI updates its strategy in a meeting with shareholders, investors and analysts


TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION

(COMISIÓN NACIONAL DEL MERCADO DE VALORES)

Madrid, 23 November 2022

In compliance with the reporting requirements provided for in article 227 of the consolidated text of the Securities Market Act, ROVI sends and publishes the attached presentation regarding the update of the company strategy, a presentation that will be distributed today and which can be accessed through the website of the company. Likewise, ROVI will hold an in-person and virtual meeting today with analysts and investors to present said presentation.

 

Mr. Juan López-Belmonte Encina

Chairman and Chief Executive Officer

Laboratorios Farmacéuticos ROVI, S.A.

 

Average: 3 (2 votes)
 
Related
The Community of Madrid has declared this project to be strategic: it will create 200 new direct jobs for 2027 and raise the plant’s...
4 min
11/07/2024
​ The company will be submitting for the approval of the Ordinary General Shareholders’ Meeting the annual accounts for the financial...
9 min
24/06/2024
​The new facility has meant an investment of 11 million euros This new line, which has now been authorised to commence commercial...
3 min
20/06/2024